We are live on ! Find out more
Jane Street

Jane Street Portfolio holdings

AUM $777B
1-Year Est. Return 61.18%
 

Jane Street Group, founded in 2000 by Tim Reynolds, Rob Granieri, Marc Gerstein, and Michael Jenkins, is a New York City-based quantitative trading firm renowned for its technological prowess and collaborative problem-solving culture. Specializing in liquidity provision and market-making, it trades a vast array of financial products—including equities, bonds, options, and ETFs—across over 200 venues in 45 countries, handling trillions in securities annually. The firm, which employs over 2,600 people across offices in New York, London, Hong Kong, Amsterdam, Chicago, and Singapore, leverages advanced algorithms and a nearly 70-million-line OCaml codebase to dominate markets, notably ETFs, where it plays a critical role as an authorized participant. With net trading revenues exceeding $10 billion annually in recent years, including a record $10.6 billion in 2023, Jane Street has emerged as a secretive yet powerful force in global finance, outpacing traditional Wall Street giants like Goldman Sachs in trading profitability.

This Fund
S&P 500
This Quarter Est. Return
-3.51%
1 Year Est. Return
+61.18%
3 Year Est. Return
+147.64%
5 Year Est. Return
+157.48%
10 Year Est. Return
+673.77%
AUM
$309B
AUM Growth
+$5.99B
Cap. Flow
+$25.7B
Cap. Flow %
8.32%
Top 10 Hldgs %
33.91%
Holding
11,631
New
1,655
Increased
4,388
Reduced
3,977
Closed
1,450

Sector Composition

Rank Sector Weight
1 Technology 2.2%
2 Consumer Discretionary 1.52%
3 Communication Services 1.07%
4 Financials 1.06%
5 Healthcare 0.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IGC icon
10001
IGC Pharma
IGC
$26.8M
$11K ﹤0.01%
11,991
-2,439
-17% -$2.37K
SNGX icon
10002
Soligenix
SNGX
$5.81M
$11K ﹤0.01%
+62
New +$9.97K
TANH icon
10003
Tantech Holdings
TANH
$6.1M
$11K ﹤0.01%
+24
New +$56.5K
YCBD icon
10004
cbdMD
YCBD
$5.93M
$11K ﹤0.01%
+30
New +$10.1K
ALPP
10005
CALL
DELISTED
Alpine 4 Holdings Inc
ALPP
$11K ﹤0.01%
1,325
-400
-23% -$4.89K
MVLAW
10006
DELISTED
Movella Holdings Inc. Warrant
MVLAW
$11K ﹤0.01%
30,031
+202
+0.7% +$94
MARK
10007
PUT
DELISTED
Remark Holdings, Inc.
MARK
$11K ﹤0.01%
1,360
-4,380
-76% -$36.6K
HHLA.WS
10008
DELISTED
HH&L Acquisition Co. Redeemable warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50
HHLA.WS
$11K ﹤0.01%
43,213
-3,595
-8% -$1.37K
TBLT
10009
DELISTED
ToughBuilt Industries, Inc. Common Stock
TBLT
$11K ﹤0.01%
+6
New +$13.9K
APGNW
10010
DELISTED
Apexigen, Inc. WarrantApexigen, Inc. Warrant
APGNW
$11K ﹤0.01%
26,271
-36
-0.1% -$12
BWACW
10011
DELISTED
BETTER WORLD ACQUISITION CORP. Warrants
BWACW
$11K ﹤0.01%
63,948
+1,751
+3% +$494
TMDI
10012
DELISTED
Titan Medical Inc. Ordinary Shares
TMDI
$11K ﹤0.01%
19,999
-1,330
-6% -$771
ELOX
10013
DELISTED
Eloxx Pharmaceuticals, Inc. Common Stock
ELOX
$11K ﹤0.01%
+509
New +$10K
LHC.WS
10014
DELISTED
Leo Holdings Corp. II Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
LHC.WS
$11K ﹤0.01%
31,515
+645
+2% +$317
HTPA.WS
10015
DELISTED
Highland Transcend Partners I Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
HTPA.WS
$11K ﹤0.01%
34,873
+349
+1% +$364
CRU.WS
10016
DELISTED
Crucible Acquisition Corporation Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
CRU.WS
$11K ﹤0.01%
34,437
-3,484
-9% -$1.65K
SLHG
10017
DELISTED
Skylight Health Group Inc Common Shares
SLHG
$11K ﹤0.01%
10,835
-4,465
-29% -$4.5K
CARM
10018
CALL
DELISTED
Carisma Therapeutics
CARM
$10K ﹤0.01%
830
-8,275
-91% -$116K
GRABW icon
10019
Grab Holdings Warrant
GRABW
$738K
$10K ﹤0.01%
12,607
-481
-4% -$620
LDTCW
10020
DELISTED
LeddarTech Holdings Inc. Warrants
LDTCW
$10K ﹤0.01%
34,846
-955
-3% -$424
REVBW icon
10021
Revelation Biosciences Warrant
REVBW
$10K ﹤0.01%
75,690
+20,620
+37% +$5.27K
GPUS
10022
CALL
Hyperscale Data Inc
GPUS
$55.4M
0
SEEL
10023
CALL
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
$10K ﹤0.01%
3
-4
-57% -$17.2K
BIOL
10024
DELISTED
Biolase, Inc.
BIOL
$10K ﹤0.01%
+12
New +$11.1K
DRCTW
10025
DELISTED
Direct Digital Holdings, Inc. Warrant
DRCTW
$10K ﹤0.01%
+14,200
New +$7.99K

Similar funds

Jane Street's Q1 2022 Portfolio in Review

As of Q1 2022, Jane Street held 11,631 positions worth $309B, up 2% from $303B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Jane Street deployed $25.7B of net new capital in Q1 2022, opening 1,655 new positions and adding to 4,388 existing holdings. Its largest new stake was VanEck JP Morgan EM Local Currency Bond ETF: 7,670,482 shares worth $207M.

By sector, the portfolio is most concentrated in Technology at 2.2% of assets, down from 2.9% a quarter earlier, followed by Consumer Discretionary and Communication Services.

On the sell side, the largest reduction was Apple, an estimated $1.61B trimmed.

  • Jane Street's largest Q1 2022 buy was VanEck JP Morgan EM Local Currency Bond ETF: 7,670,482 shares worth $207M.
  • Jane Street added most to Vanguard FTSE Europe ETF in Q1 2022, an estimated $869M increase.
  • Jane Street's biggest Q1 2022 reduction was Apple, cutting an estimated $1.61B.
  • Jane Street fully exited iShares MBS ETF in Q1 2022, selling an estimated $335M.
  • Jane Street's ten largest holdings make up 34% of its $309B portfolio in Q1 2022.
  • Jane Street opened 1,655 new positions and closed 1,450 in Q1 2022.
  • Jane Street's portfolio value rose 2% quarter-over-quarter to $309B.

Based on Jane Street's 13F filing for Q1 2022, filed 17 May 2022.